These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20518271)

  • 1. Rational use of immunodiagnostic tools for tuberculosis infection: guidelines and cost effectiveness studies.
    Amicosante M; Ciccozzi M; Markova R
    New Microbiol; 2010 Apr; 33(2):93-107. PubMed ID: 20518271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is the tuberculin skin test still suitable to diagnose tuberculosis infection ?].
    de Kantor IN; Ritacco V
    Medicina (B Aires); 2009; 69(3):359-69. PubMed ID: 19622488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
    Harada N
    Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon gamma release assays: principles and practice.
    Lalvani A; Pareek M
    Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):245-52. PubMed ID: 19783328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings.
    Dheda K; van Zyl Smit R; Badri M; Pai M
    Curr Opin Pulm Med; 2009 May; 15(3):188-200. PubMed ID: 19387262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis.
    Pai M; Kalantri S; Dheda K
    Expert Rev Mol Diagn; 2006 May; 6(3):413-22. PubMed ID: 16706743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection.
    Codecasa L; Mantegani P; Galli L; Lazzarin A; Scarpellini P; Fortis C
    J Clin Microbiol; 2006 Jun; 44(6):1944-50. PubMed ID: 16757583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of interferon-gamma whole blood assay with tuberculin skin test for the diagnosis of tuberculosis infection in tuberculosis contacts].
    Oztürk N; Sürücüoğlu S; Ozkütük N; Gazi H; Akçali S; Köroğlu G; Ciçek C
    Mikrobiyol Bul; 2007 Apr; 41(2):193-202. PubMed ID: 17682705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Basic characteristics of a novel diagnostic method (QuantiFERON TB-2G) for latent tuberculosis infection with the use of Mycobacterium tuberculosis-specific antigens, ESAT-6 and CFP-10].
    Harada N; Higuchi K; Sekiya Y; Rothel J; Kitoh T; Mori T
    Kekkaku; 2004 Dec; 79(12):725-35. PubMed ID: 15782618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly discordant T cell responses in individuals with recent exposure to household tuberculosis.
    Hesseling AC; Mandalakas AM; Kirchner HL; Chegou NN; Marais BJ; Stanley K; Zhu X; Black G; Beyers N; Walzl G
    Thorax; 2009 Oct; 64(10):840-6. PubMed ID: 18682523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers.
    de Perio MA; Tsevat J; Roselle GA; Kralovic SM; Eckman MH
    Arch Intern Med; 2009 Jan; 169(2):179-87. PubMed ID: 19171815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma release assays: new diagnostic tests for Mycobacterium tuberculosis infection, and their use in children.
    Lewinsohn DA; Lobato MN; Jereb JA
    Curr Opin Pediatr; 2010 Feb; 22(1):71-6. PubMed ID: 19952926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in Mycobacterium tuberculosis specific immune responses in patients with untreated psoriasis living in a tuberculosis endemic area.
    Silva LC; Silveira GG; Arnone M; Romiti R; Geluk A; Franken KC; Duarte AJ; Takahashi MD; Benard G
    Arch Dermatol Res; 2010 May; 302(4):255-62. PubMed ID: 19609541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an in vitro assay for interferon gamma production in response to the Mycobacterium tuberculosis-synthesized peptide antigens ESAT-6 and CFP-10 and the PPD skin test.
    Taggart EW; Hill HR; Ruegner RG; Litwin CM
    Am J Clin Pathol; 2006 Mar; 125(3):467-73. PubMed ID: 16613353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of interferon-gamma release assays in healthcare workers.
    Swindells JE; Aliyu SH; Enoch DA; Abubakar I
    J Hosp Infect; 2009 Oct; 73(2):101-8. PubMed ID: 19699551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel screening tools for latent tuberculosis: time to leave an old friend?
    Villiger PM; Zellweger JP; Möller B
    Curr Opin Rheumatol; 2009 May; 21(3):238-43. PubMed ID: 19346950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma release assays (IGRAs) in high-endemic settings: could they play a role in optimizing global TB diagnostics? Evaluating the possibilities of using IGRAs to diagnose active TB in a rural African setting.
    Barth RE; Mudrikova T; Hoepelman AI
    Int J Infect Dis; 2008 Nov; 12(6):e1-6. PubMed ID: 18565778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A view of dynamics of immune responses against tuberculosis infection through QFT].
    Harada N
    Kekkaku; 2011 Jul; 86(7):743-9. PubMed ID: 21922785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines on interferon-γ release assays for tuberculosis infection: concordance, discordance or confusion?
    Denkinger CM; Dheda K; Pai M
    Clin Microbiol Infect; 2011 Jun; 17(6):806-14. PubMed ID: 21682801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.